Aminologics Co.Ltd (074430) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aminologics Co.Ltd (074430) has a cash flow conversion efficiency ratio of 0.081x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.62 Billion ≈ $3.13 Million USD) by net assets (₩57.11 Billion ≈ $38.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Aminologics Co.Ltd for the company's overall valuation and market capitalisation.
Aminologics Co.Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Aminologics Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Aminologics Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aminologics Co.Ltd ranked by their cash flow conversion efficiency. Explore Aminologics Co.Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nature Holdings Co. Ltd.
KQ:298540
|
0.027x |
|
LeonaBio, Inc.
NASDAQ:LONA
|
-0.424x |
|
Anam Electroni
KO:008700
|
-0.077x |
|
Dawonsys Co.Ltd
KQ:068240
|
0.103x |
|
Alterity Therapeutics Limited
F:PBN
|
-0.093x |
|
Futebol Clube do Porto - Futebol S.A.D.
LS:FCP
|
-0.266x |
|
Where Food Comes From Inc
NASDAQ:WFCF
|
0.106x |
|
Arizona Gold & Silver Inc.
V:AZS
|
-0.042x |
Annual Cash Flow Conversion Efficiency for Aminologics Co.Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Aminologics Co.Ltd from 2008 to 2025. View Aminologics Co.Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩55.99 Billion ≈ $37.95 Million |
₩2.54 Billion ≈ $1.72 Million |
0.045x | -68.58% |
| 2024-12-31 | ₩51.70 Billion ≈ $35.03 Million |
₩7.47 Billion ≈ $5.06 Million |
0.144x | +3702.19% |
| 2023-12-31 | ₩54.41 Billion ≈ $36.87 Million |
₩-218.15 Million ≈ $-147.84K |
-0.004x | -103.94% |
| 2022-12-31 | ₩51.40 Billion ≈ $34.84 Million |
₩5.23 Billion ≈ $3.54 Million |
0.102x | +545.46% |
| 2021-12-31 | ₩59.39 Billion ≈ $40.25 Million |
₩935.52 Million ≈ $633.99K |
0.016x | -52.29% |
| 2020-12-31 | ₩53.56 Billion ≈ $36.30 Million |
₩1.77 Billion ≈ $1.20 Million |
0.033x | -52.50% |
| 2019-12-31 | ₩51.85 Billion ≈ $35.14 Million |
₩3.60 Billion ≈ $2.44 Million |
0.070x | -18.90% |
| 2018-12-31 | ₩53.19 Billion ≈ $36.04 Million |
₩4.56 Billion ≈ $3.09 Million |
0.086x | +28.94% |
| 2017-12-31 | ₩45.14 Billion ≈ $30.59 Million |
₩3.00 Billion ≈ $2.03 Million |
0.066x | -28.45% |
| 2016-12-31 | ₩44.55 Billion ≈ $30.19 Million |
₩4.14 Billion ≈ $2.80 Million |
0.093x | +132.53% |
| 2015-12-31 | ₩48.28 Billion ≈ $32.72 Million |
₩1.93 Billion ≈ $1.31 Million |
0.040x | +161.59% |
| 2014-12-31 | ₩31.85 Billion ≈ $21.58 Million |
₩-2.07 Billion ≈ $-1.40 Million |
-0.065x | -127.90% |
| 2008-12-31 | ₩52.44 Billion ≈ $35.54 Million |
₩12.19 Billion ≈ $8.26 Million |
0.233x | -- |
About Aminologics Co.Ltd
Aminologics Co.,Ltd., a specialty amino acid provider, develops a range of amino-acid-based raw materials for pharmaceutical and fine chemical industries in South Korea. Its products include D-phenylalanine, D-alanine, D-cysteine, D-serine, D-allo-isoleucine, D-allo-threonine, S-beta-phenylalanine, 3-(2-napthyl)-D-alanine, 4-chloro-D-phenylalanine, 3-(2-napthyl)-L-alanine, R-beta-phenylalanine, D… Read more